QTRX (Quanterix) Current Deferred Revenue : $10.1 Mil (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Quanterix Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Quanterix's current deferred revenue for the quarter that ended in Jun. 2024 was $10.1 Mil.

Quanterix Current Deferred Revenue Historical Data

The historical data trend for Quanterix's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quanterix Current Deferred Revenue Chart

Quanterix Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Deferred Revenue

Get a 7-Day Free Trial

4.70

5.42

6.36

8.64

9.47

Quanterix Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Current Deferred Revenue	Get a 7-Day Free Trial															10.42	9.83	9.47	10.23	10.12

Quanterix Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Quanterix's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Quanterix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Quanterix Corp (NAS:QTRX) » Definitions » Current Deferred Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 Middlesex Turnpike, Billerica, MA, USA, 01821

Website

https://www.quanterix.com

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.

Executives

David R Walt	director	5200 ILLUMINA WAY, SAN DIEGO CA 92122
Masoud Toloue	officer: President, Quanterix & Dx	C/O QUANTERIX CORP, 900 MIDDLESEX TURNPIKE, BILLERICA MA 01821
Laurie J Olson	director	C/O PFIZER INC. CORPORATE SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
William P Donnelly	director	C/O INGERSOLL RAND INC., 525 HARBOUR PLACE DRIVE, SUITE 600, DAVIDSON NC 28036
Vandana Sriram	officer: Chief Financial Officer	15 ELIZABETH DRIVE, CHELMSFORD MA 01824
Brian J Blaser	director	561 CIRCLE LANE, LAKE FOREST IL 60045
Michael A Doyle	officer: CFO and Treasurer	C/O EASYLINK SERVICES CORPORATION, 33 KNIGHTSBRIDGE ROAD, PISCATAWAY NJ 08854
Sarah E. Hlavinka	director	2111 N MOLTER RD, LIBERTY LAKE WA 99019
Paul M Meister	director	18 SHIP ROCK ROAD, NORTH HAMPTON NH 03862
Martin D Madaus	director	290 CONCORD ROAD, BILLERICA MA 01821
John J Fry	officer: General Counsel & Secretary	8 CENTENNIAL DRIVE, PEABODY MA 01960
E Kevin Hrusovsky	director, officer: EC, President & CEO	68 ELM STREET, HOPKINTON MA 01748
Karen Flynn	director	C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
David C. Duffy	officer: SVP R&D and CTO	C/O QUANTERIX CORPORATION, 113 HARTWELL AVENUELE, LEXINGTON MA 02421
Dawn Mattoon	officer: Sr VP, Stgc Mrktg & Assay Tech	113 HARTWELL AVENUE, C/O QUANTERIX CORPORATION, LEXINGTON MA 02421